Pediatrix Medical Group Inc/ US58502B1061 /
2024-04-25 10:10:00 PM | Chg. -0.34 | Volume | Bid2:00:00 AM | Ask2:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
8.90USD | -3.68% | 424,742 Turnover: 2.82 mill. |
7.00Bid Size: 100 | 22.22Ask Size: 100 | 748.69 mill.USD | - | 12.19 |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 94.4920 | 76.1910 | 70.1540 | 73.2900 | 75.6390 | ||||||
Intangible Assets | 274.4070 | 26.6420 | 21.5650 | 18.4910 | 21.2400 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | 3,414.3940 | 1,798.6000 | 1,881.9820 | 1,919.8980 | 1,736.3560 | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | 498.8690 | 241.9310 | 301.7750 | 296.7870 | 272.3130 | ||||||
Cash and Cash Equivalents | 112.7670 | 1,123.8430 | 387.3910 | 9.8240 | 73.2580 | ||||||
Current Assets | 731.5070 | 1,549.3480 | 840.5640 | 427.9890 | 483.4540 | ||||||
Total Assets | 4,145.9010 | 3,347.9480 | 2,722.5460 | 2,347.8870 | 2,219.8100 |
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | - | - | - | - | - | ||||||
Long-term debt | 1,730.2950 | 1,742.5860 | 1,002.2580 | 632.3810 | 618.4210 | ||||||
Liabilities to Banks | 0.0000 | - | - | - | - | ||||||
Provisions | 64.5000 | - | - | - | - | ||||||
Liabilities | 2,646.9050 | 2,600.2310 | 1,825.8540 | 1,456.2550 | 1,370.7490 | ||||||
Share Capital | .8420 | .8560 | .8640 | .8290 | .8400 | ||||||
Total Equity | 1,498.9960 | 747.7170 | 896.6920 | 891.6320 | 849.0610 | ||||||
Minority Interests | - | .2320 | .2050 | 0.0000 | 0.0000 | ||||||
Total liabilities equity | 4,145.9010 | 3,347.9480 | 2,722.5460 | 2,347.8870 | 2,219.8100 |
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 3,513.5420 | 1,733.9510 | 1,911.1910 | 1,972.0210 | 1,994.6400 | ||||||
Depreciation (total) | 78.8600 | 28.4410 | 32.1470 | 35.6360 | 36.1710 | ||||||
Operating Result | -1,136.0490 | 98.1320 | 202.9180 | 172.6880 | 7.3210 | ||||||
Interest Income | -119.3810 | -110.4820 | -68.7220 | -39.6950 | -42.0750 | ||||||
Income Before Taxes | -1,241.9800 | 7.1480 | 135.2280 | 81.3700 | -48.3590 | ||||||
Income Taxes | 91.8860 | -16.7280 | -27.2410 | -18.8060 | -12.0490 | ||||||
Minority Interests Profit | - | - | .0270 | .0040 | 0.0000 | ||||||
Net Income | -1,497.7020 | -796.4880 | 130.9640 | 66.3350 | -60.4080 |
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 346.6370 | 204.6200 | 76.7370 | 166.9410 | 137.3250 | ||||||
Cash Flow from Investing Activities | 102.4550 | 815.5110 | -53.0730 | -56.9540 | -48.1760 | ||||||
Cash Flow from Financing | -393.0700 | -4.1580 | -760.1160 | -487.5540 | -25.7150 | ||||||
Decrease / Increase in Cash | 56.0220 | 1,015.9730 | -736.4520 | -377.5670 | 63.4340 | ||||||
Employees | 4,325 | - | - | - | - |